In line with these results, the European Society of Cardiology guidelines and the American Diabetes Association have recommended the use of GLP-1 RA in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases [76] (Table 1). The gene discussed is GCG; the disease is type 2 diabetes mellitus.